Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
Clinical trial NCT03654547 · COMPLETED
Trial details
- NCT number
- NCT03654547
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2023-01-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.